Results 181 to 190 of about 3,132 (216)
Some of the next articles are maybe not open access.
Canadian Journal of Health Technologies, 2022
CADTH reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform non-binding recommendations that help guide the reimbursement decisions of Canada's federal, provincial, and territorial governments ...
openaire +1 more source
CADTH reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform non-binding recommendations that help guide the reimbursement decisions of Canada's federal, provincial, and territorial governments ...
openaire +1 more source
Journal of Clinical Medicine
Background/Objectives: Macular edema (ME), due to retinal vein occlusion (RVO), is a major cause of vision impairment. Many patients experience suboptimal responses to anti-vascular endothelial growth factor (anti-VEGF) monotherapy, necessitating ...
M. Hafner +7 more
semanticscholar +1 more source
Background/Objectives: Macular edema (ME), due to retinal vein occlusion (RVO), is a major cause of vision impairment. Many patients experience suboptimal responses to anti-vascular endothelial growth factor (anti-VEGF) monotherapy, necessitating ...
M. Hafner +7 more
semanticscholar +1 more source
Scientific Reports
To evaluate the outcomes and predictive factors for fluid resolution following three loading injections of faricimab for neovascular age-related macular degeneration(AMD).
Hee-Yong Han +6 more
semanticscholar +1 more source
To evaluate the outcomes and predictive factors for fluid resolution following three loading injections of faricimab for neovascular age-related macular degeneration(AMD).
Hee-Yong Han +6 more
semanticscholar +1 more source
Graefe's Archive for Clinical and Experimental Ophthalmology
To explore the 1-year functional and anatomic outcomes of treatment-naïve neovascular age-related macular degeneration (nAMD) eyes undergoing a treat and extend (TAE) regimen with faricimab, Prospective interventional study on 33 eyes with treatment ...
Alessandra Scampoli +6 more
semanticscholar +1 more source
To explore the 1-year functional and anatomic outcomes of treatment-naïve neovascular age-related macular degeneration (nAMD) eyes undergoing a treat and extend (TAE) regimen with faricimab, Prospective interventional study on 33 eyes with treatment ...
Alessandra Scampoli +6 more
semanticscholar +1 more source
DiagnosticsTo assess changes in choriocapillaris (CC) vascular density surrounding macular neovascularization (MNV) in age-related macular degeneration (AMD) when transitioning from various anti-VEGF treatments to faricimab, using optical coherence tomography ...
Pasquale Viggiano +2 more
exaly +3 more sources
Ophthalmology Retina
PURPOSE To report one-year anatomical and functional real-world outcomes of treatment intensive neovascular age related macular degeneration (nAMD) patients switched to faricimab DESIGN: Retrospective multi-centre cohort study SUBJECTS: Consecutive nAMD ...
Sing Yue Sim +10 more
semanticscholar +1 more source
PURPOSE To report one-year anatomical and functional real-world outcomes of treatment intensive neovascular age related macular degeneration (nAMD) patients switched to faricimab DESIGN: Retrospective multi-centre cohort study SUBJECTS: Consecutive nAMD ...
Sing Yue Sim +10 more
semanticscholar +1 more source
Faricimab-Associated Retinal Vasculitis
Journal of VitreoRetinal DiseasesPurpose: To report a case of retinal vasculitis after intravitreal faricimab-svoa injection. Methods: A case and its management were reviewed. Results: A 77-year-old woman presented with a painless decrease in visual acuity (VA) to counting fingers after receiving an intravitreal faricimab-svoa injection for neovascular age-related macular ...
Mohammad Z. Siddiqui +2 more
openaire +2 more sources
Retina
Supplemental Digital Content is Available in the Text. Post hoc analysis of phase 3 YOSEMITE/RHINE trials found that intravitreal faricimab every 8 weeks (Q8W) for 2 years reduced epiretinal membrane (ERM) formation in eyes with diabetic macular edema ...
Glenn J. Jaffe +11 more
semanticscholar +1 more source
Supplemental Digital Content is Available in the Text. Post hoc analysis of phase 3 YOSEMITE/RHINE trials found that intravitreal faricimab every 8 weeks (Q8W) for 2 years reduced epiretinal membrane (ERM) formation in eyes with diabetic macular edema ...
Glenn J. Jaffe +11 more
semanticscholar +1 more source
Canadian Journal of Health Technologies
Canada’s Drug Agency (CDA-AMC) recommends that Vabysmo be reimbursed by public drug plans for the treatment of macular edema secondary to retinal vein occlusion (RVO) if certain conditions are met. Vabysmo should be covered to treat patients with macular edema secondary to RVO provided that it is covered for a similar patient population to other ...
openaire +1 more source
Canada’s Drug Agency (CDA-AMC) recommends that Vabysmo be reimbursed by public drug plans for the treatment of macular edema secondary to retinal vein occlusion (RVO) if certain conditions are met. Vabysmo should be covered to treat patients with macular edema secondary to RVO provided that it is covered for a similar patient population to other ...
openaire +1 more source
Ophthalmic Surgery Lasers and Imaging Retina
BACKGROUND AND OBJECTIVE To assess the efficacy of intravitreal aflibercept 8 mg in treating neovascular age-related macular degeneration (nAMD) in patients previously treated with faricimab.
Bita Momenaei +4 more
semanticscholar +1 more source
BACKGROUND AND OBJECTIVE To assess the efficacy of intravitreal aflibercept 8 mg in treating neovascular age-related macular degeneration (nAMD) in patients previously treated with faricimab.
Bita Momenaei +4 more
semanticscholar +1 more source